Target intelligence / Profile preview

Scavenger receptor class B member 2 (SCARB2)

Target
SCARB2
Molecular classification
Receptor, Transporter, CD36 family, Lysosomal membrane protein
01

Overview

Scavenger receptor class B member 2 (SCARB2), also known as Lysosomal integral membrane protein 2 (LIMP-2, or LGP85, CD36b like-2), is a highly glycosylated lysosomal membrane protein of 478 amino acids and a member of the CD36 family[1][3][6]. It is essential for the transport of beta-glucocerebrosidase from the endoplasmic reticulum to lysosomes, where it maintains lysosomal structure and function[3][6]. SCARB2 also transiently shuttles to the plasma membrane and serves as the entry receptor for certain picornaviruses, notably enterovirus 71 and some coxsackieviruses[1][3]. Mutations in the SCARB2 gene are associated with lysosomal storage disorders, particularly action myoclonus–renal failure syndrome (AMRF), which combines neurological and renal symptoms[1][3]. SCARB2 is widely expressed in tissues including the brain, heart, liver, and macrophages[5][3]. Besides lysosomal cell biology, its surface expression can make cells susceptible to viral infection, and SCARB2 dysfunction has implications for neurodegenerative and infectious diseases[1][3][5][6].

Other names
Lysosomal integral membrane protein 2 (LIMP-2)Lysosomal glycoprotein 85 (LGP85)CD36b like-2
02

Mechanism of action

As a viral receptor: mediates viral entry for certain enteroviruses by binding and promoting endocytosis. As a lysosomal transporter: mediates lysosomal trafficking of beta-glucocerebrosidase by facilitating its delivery and membrane fusion.

03

Biological functions

Transport of beta-glucocerebrosidase to lysosomeEndosomal/lysosomal membrane traffickingVirus receptor activity (e.g., for enterovirus 71 and some coxsackieviruses)Regulation of lysosomal stability
04

Disease associations

Neurodegenerative disease (e.g., AMRF syndrome: action myoclonus–renal failure syndrome)Infection (e.g., Hand, foot, and mouth disease due to EV71 and coxsackievirus A7, A14, A16)Cardiovascular disease (implicated through lysosomal and lipid pathway roles)
05

Safety considerations

Loss of function or mutations can lead to action myoclonus–renal failure syndrome (AMRF)Deficiency causes neurodegeneration, peripheral neuropathy, deafness, and kidney dysfunction in humans and mice
06

Interacting drugs

There are no broadly used, FDA-approved small-molecule drugs known to directly target SCARB2 as of the latest literature.
07

Biomarkers

Mutations can be used as biomarkers for action myoclonus–renal failure syndromeMay be studied as a marker for susceptibility to some viral infections

Beyond the preview

Go deeper on Scavenger receptor class B member 2 (SCARB2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Scavenger receptor class B member 2 (SCARB2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call